BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28263231)

  • 21. Toward the molecular dissection of peritoneal pseudomyxoma.
    Pietrantonio F; Perrone F; Mennitto A; Gleeson EM; Milione M; Tamborini E; Busico A; Settanni G; Berenato R; Caporale M; Morano F; Bossi I; Pellegrinelli A; Di Bartolomeo M; de Braud F; Baratti D; Bowne WB; Kusamura S; Deraco M
    Ann Oncol; 2016 Nov; 27(11):2097-2103. PubMed ID: 27502722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
    Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei.
    Saarinen L; Nummela P; Leinonen H; Heiskanen A; Thiel A; Haglund C; Lepistö A; Satomaa T; Hautaniemi S; Ristimäki A
    Mol Cell Proteomics; 2018 Nov; 17(11):2107-2118. PubMed ID: 30072579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.
    Szych C; Staebler A; Connolly DC; Wu R; Cho KR; Ronnett BM
    Am J Pathol; 1999 Jun; 154(6):1849-55. PubMed ID: 10362811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
    Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.
    Semino-Mora C; Liu H; McAvoy T; Nieroda C; Studeman K; Sardi A; Dubois A
    Ann Surg Oncol; 2008 May; 15(5):1414-23. PubMed ID: 18299935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review.
    Murage NW; Ahmed NM; Underwood TJ; Walters ZS; Breininger SP
    Cancer Metastasis Rev; 2023 Mar; 42(1):335-359. PubMed ID: 36723696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.
    Sio TT; Mansfield AS; Grotz TE; Graham RP; Molina JR; Que FG; Miller RC
    J Hum Genet; 2014 Mar; 59(3):124-8. PubMed ID: 24369359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-exome sequencing identified the genetic origin of a mucinous neoplasm in a mature cystic teratoma.
    Choi YJ; Lee SH; Kim MS; Jung SH; Hur SY; Chung YJ; Lee SH
    Pathology; 2016 Jun; 48(4):372-6. PubMed ID: 27114374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells.
    Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
    Hum Cell; 2024 Mar; 37(2):511-522. PubMed ID: 38143259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
    Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
    Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
    Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
    Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei.
    Saarinen L; Nummela P; Thiel A; Lehtonen R; Järvinen P; Järvinen H; Aaltonen LA; Lepistö A; Hautaniemi S; Ristimäki A
    PLoS One; 2017; 12(4):e0174898. PubMed ID: 28426742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomyxoma peritonei with intrathoracic extension: a rare disease with rarer presentation from low-grade mucinous adenocarcinoma of the appendix.
    Ghosh RK; Somasundaram M; Ravakhah K; Hassan C
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26729823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients.
    Taflampas P; Dayal S; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2014 May; 40(5):515-520. PubMed ID: 24462284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.
    Kuracha MR; Thomas P; Loggie BW; Govindarajan V
    Cancer Med; 2016 Apr; 5(4):711-9. PubMed ID: 26833741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report.
    Shelekhova KV; Zhuravlev AS; Krylova DD; Konstantinov AS; Shtan LV; Kheinshtein VA
    Int J Surg Pathol; 2017 Sep; 25(6):563-566. PubMed ID: 28449606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.
    Lin YL; Zhu JQ; Ma RQ; Meng W; Wang ZY; Li XB; Ma R; Wu HL; Xu HB; Gao Y; Li Y
    Mol Cancer Res; 2024 Jan; 22(1):70-81. PubMed ID: 37768171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.
    O'Connell JT; Tomlinson JS; Roberts AA; McGonigle KF; Barsky SH
    Am J Pathol; 2002 Aug; 161(2):551-64. PubMed ID: 12163380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.